Shekhar Suman’s ₹700-crore Delhi hospital procurement joke points to an alleged fraud whose final loss is still under investigation

In a July 17, 2026 Instagram reel published by Shekhar Tonite, Shekhar Suman says that a ₹700-crore scam has surfaced in the purchase of equipment and other essential supplies used in Delhi hospitals. He then turns the allegation into a joke about the familiar “mandir ke jagah aspataal” argument, saying that even after building hospitals the result is the same, with only ₹100–200 crore of difference.

The immediate factual anchor is real but needs an important qualification. Delhi’s Anti-Corruption Branch is investigating alleged large-scale irregularities in procurement by the Directorate General of Health Services and the Central Procurement Agency. Reporting based on the Vigilance complaint, FIR and investigators’ submissions describes alleged inflated prices, manipulated tenders and shell or front firms across medicines, surgical supplies, consumables and medical equipment. The figure commonly reported as ₹700 crore is an estimate associated with the alleged procurement fraud; investigators have also said they had not reached a final conclusion on the total financial loss.

What the investigation alleges

Examples reported from the investigation include portable X-ray machines allegedly purchased for about ₹33 lakh each against an indicated market cost of roughly ₹10 lakh, bedsheets allegedly bought for ₹450 against about ₹150, and ORS sachets allegedly procured for ₹15 against about ₹2.50. The ACB has arrested former senior health and procurement officials, while investigators have alleged that tender specifications were manipulated to favour selected suppliers. These remain allegations in an ongoing criminal investigation, not final judicial findings of guilt.

The wider issue is procurement governance, not hospitals versus temples

Suman’s punchline reframes a procurement-corruption allegation as a comment on whether public money should go to hospitals or temples. The evidence does not establish that building hospitals produces the same outcome as building temples, nor does the alleged procurement case test the social value of either kind of institution. What it does expose is a narrower and more consequential governance question: whether public-health spending reaches patients through procurement systems that are competitive, documented and accountable.

That issue predates the current criminal case. A Comptroller and Auditor General performance audit of Delhi’s health services found persistent weaknesses in the Central Procurement Agency during 2016–17 to 2021–22, including failures to ensure timely supply of essential drugs and problems in medical-equipment procurement. This audit does not prove the allegations in the 2026 FIR, but it provides independent evidence that procurement capacity and controls were already an institutional vulnerability.

The government has since changed the procurement arrangement on an interim basis, putting centralised purchasing on hold and allowing individual hospitals to procure medicines, surgical items and equipment directly. That response shows the alleged fraud has already affected how Delhi’s public-health purchasing system operates, even while criminal responsibility and the precise financial loss remain unresolved.

What can and cannot be concluded

The reel is best understood as satire built around a genuine ongoing investigation. Its ₹700-crore wording broadly matches the scale publicly attributed to the case, but it presents the amount as a settled “scam” figure when the investigation has not established a final loss and courts have not made final findings of guilt. The stronger public-interest conclusion is therefore not Suman’s hospitals-versus-temples comparison: it is that alleged tender manipulation and inflated medical purchasing have raised serious questions about safeguards around public-health procurement, with the extent of loss and individual culpability still to be determined.